financetom
Business
financetom
/
Business
/
US FDA approves Sanofi-Regeneron's Dupixent for 'smoker's lung'
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA approves Sanofi-Regeneron's Dupixent for 'smoker's lung'
Sep 29, 2024 12:24 AM

Sept 27 (Reuters) - The U.S. Food and Drug

Administration has approved Sanofi and Regeneron's

blockbuster drug Dupixent for patients with a chronic

lung disease commonly known as "smoker's lung", the companies

said on Friday.

(Reporting by Sriparna Roy in Bengaluru; Editing by Sriraj

Kalluvila)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved